Compound Detail
CHEMBL145735
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL145735 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DFFCDIMSXJYMTB-AATRIKPKSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
344.4
MW (Da)
2.18
ALogP
4
HBA
6
HBD
157.1
PSA (Ų)
0.25
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 2 meas. best 4.48
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Ki | 4.48 | 4.48 | 33200.0 | 1 |
| Glandular kallikrein CHEMBL3243909 | Ki | 4.0 | 4.0 | 100000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | Ki | = | 33200.0 | nM | 4.48 | Competitive reversible inhibition of bovine trypsin using alpha-N-benzoyl-DL-arg... | 671460 |
| Glandular kallikrein | Ki | = | 100000.0 | nM | 4.0 | Competitive reversible inhibition of porcine pancreatic kallikrein using alpha-N... | 671460 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 8691476 | 10.1021/jm9507946 | Nucleic Acid | 5 |
| 8510102 | 10.1021/jm00064a008 | Nucleic Acid | 4 |
| 7490723 | 10.1021/jm00024a001 | Pneumocystis carinii | 2 |
| 19635954 | 10.1128/aac.01709-08 | Bacillus anthracis | 2 |
| 671460 | 10.1021/jm00205a005 | Plasma | 2 |
| 8510102 | 10.1021/jm00064a008 | Calf thymus DNA | 1 |
| 6157024 | 10.1021/jm00181a016 | Gag-Pol polyprotein | 1 |
| 671460 | 10.1021/jm00205a005 | Prothrombin | 1 |
| 671460 | 10.1021/jm00205a005 | Glandular kallikrein | 1 |
| 671460 | 10.1021/jm00205a005 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine